Genescient is a cutting-edge biotechnology company that merges evolutionary genomics with extensive selective screening to explore and harness the potential of the genetics found in animal and human whole genomes. With this approach, Genescient has the ability to create innovative therapeutics that target chronic diseases associated with aging. One of their standout achievements is the development of Methuselah Flies, known for their exceptional vigor and vitality.

These flies not only outperform other flies but also have the ability to attract and claim mates from their counterparts. Through their research, Genescient has discovered that aging is not solely a result of accumulated damage, but rather a complex interplay of genetic and environmental factors. By decoding the intricate mechanisms underlying aging, Genescient aims to pave the way for groundbreaking advancements in the field of anti-aging therapeutics